BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 19323649)

  • 1. Emerin-prelamin A interplay in human fibroblasts.
    Capanni C; Del Coco R; Mattioli E; Camozzi D; Columbaro M; Schena E; Merlini L; Squarzoni S; Maraldi NM; Lattanzi G
    Biol Cell; 2009 Sep; 101(9):541-54. PubMed ID: 19323649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamin A precursor induces barrier-to-autointegration factor nuclear localization.
    Capanni C; Cenni V; Haraguchi T; Squarzoni S; Schüchner S; Ogris E; Novelli G; Maraldi N; Lattanzi G
    Cell Cycle; 2010 Jul; 9(13):2600-10. PubMed ID: 20581439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome.
    Mallampalli MP; Huyer G; Bendale P; Gelb MH; Michaelis S
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14416-21. PubMed ID: 16186497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.
    Toth JI; Yang SH; Qiao X; Beigneux AP; Gelb MH; Moulson CL; Miner JH; Young SG; Fong LG
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12873-8. PubMed ID: 16129834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prelamin A and lamin A appear to be dispensable in the nuclear lamina.
    Fong LG; Ng JK; Lammerding J; Vickers TA; Meta M; Coté N; Gavino B; Qiao X; Chang SY; Young SR; Yang SH; Stewart CL; Lee RT; Bennett CF; Bergo MO; Young SG
    J Clin Invest; 2006 Mar; 116(3):743-52. PubMed ID: 16511604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of distinct prelamin A variants in human diploid fibroblasts differentially affects cell homeostasis.
    Candelario J; Borrego S; Reddy S; Comai L
    Exp Cell Res; 2011 Feb; 317(3):319-29. PubMed ID: 20974128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial partial lipodystrophy, mandibuloacral dysplasia and restrictive dermopathy feature barrier-to-autointegration factor (BAF) nuclear redistribution.
    Capanni C; Squarzoni S; Cenni V; D'Apice MR; Gambineri A; Novelli G; Wehnert M; Pasquali R; Maraldi NM; Lattanzi G
    Cell Cycle; 2012 Oct; 11(19):3568-77. PubMed ID: 22935701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An accumulation of non-farnesylated prelamin A causes cardiomyopathy but not progeria.
    Davies BS; Barnes RH; Tu Y; Ren S; Andres DA; Spielmann HP; Lammerding J; Wang Y; Young SG; Fong LG
    Hum Mol Genet; 2010 Jul; 19(13):2682-94. PubMed ID: 20421363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered chromatin organization and SUN2 localization in mandibuloacral dysplasia are rescued by drug treatment.
    Camozzi D; D'Apice MR; Schena E; Cenni V; Columbaro M; Capanni C; Maraldi NM; Squarzoni S; Ortolani M; Novelli G; Lattanzi G
    Histochem Cell Biol; 2012 Oct; 138(4):643-51. PubMed ID: 22706480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear localization signal deletion mutants of lamin A and progerin reveal insights into lamin A processing and emerin targeting.
    Wu D; Flannery AR; Cai H; Ko E; Cao K
    Nucleus; 2014; 5(1):66-74. PubMed ID: 24637396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-B.
    Odinammadu KO; Shilagardi K; Tuminelli K; Judge DP; Gordon LB; Michaelis S
    Nucleus; 2023 Dec; 14(1):2288476. PubMed ID: 38050983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated interactions between lamin A and SUN1 induce abnormalities in the nuclear envelope and endoplasmic reticulum in progeric laminopathies.
    Chen ZJ; Wang WP; Chen YC; Wang JY; Lin WH; Tai LA; Liou GG; Yang CS; Chi YH
    J Cell Sci; 2014 Apr; 127(Pt 8):1792-804. PubMed ID: 24522183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria.
    Cenni V; Capanni C; Columbaro M; Ortolani M; D'Apice MR; Novelli G; Fini M; Marmiroli S; Scarano E; Maraldi NM; Squarzoni S; Prencipe S; Lattanzi G
    Eur J Histochem; 2011 Oct; 55(4):e36. PubMed ID: 22297442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamin A/C, laminopathies and premature ageing.
    Liu B; Zhou Z
    Histol Histopathol; 2008 Jun; 23(6):747-63. PubMed ID: 18366013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking farnesylation of the prelamin A variant in Hutchinson-Gilford progeria syndrome alters the distribution of A-type lamins.
    Wang Y; Ostlund C; Choi JC; Swayne TC; Gundersen GG; Worman HJ
    Nucleus; 2012; 3(5):452-62. PubMed ID: 22895092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs affecting prelamin A processing: effects on heterochromatin organization.
    Mattioli E; Columbaro M; Capanni C; Santi S; Maraldi NM; D'Apice MR; Novelli G; Riccio M; Squarzoni S; Foisner R; Lattanzi G
    Exp Cell Res; 2008 Feb; 314(3):453-62. PubMed ID: 18093584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prelamin A farnesylation and progeroid syndromes.
    Young SG; Meta M; Yang SH; Fong LG
    J Biol Chem; 2006 Dec; 281(52):39741-5. PubMed ID: 17090536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.
    Yang SH; Bergo MO; Toth JI; Qiao X; Hu Y; Sandoval S; Meta M; Bendale P; Gelb MH; Young SG; Fong LG
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10291-6. PubMed ID: 16014412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin treatment of Mandibuloacral dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamics.
    Cenni V; Capanni C; Mattioli E; Columbaro M; Wehnert M; Ortolani M; Fini M; Novelli G; Bertacchini J; Maraldi NM; Marmiroli S; D'Apice MR; Prencipe S; Squarzoni S; Lattanzi G
    Aging (Albany NY); 2014 Sep; 6(9):755-70. PubMed ID: 25324471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.
    Bifulco M; D'Alessandro A; Paladino S; Malfitano AM; Notarnicola M; Caruso MG; Laezza C
    FEBS J; 2013 Dec; 280(23):6223-32. PubMed ID: 24112551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.